A Study of LY2835219 in Healthy Participants

NCT02256267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY2835219
DRUG: Rifampin

Sponsor

Eli Lilly and Company